Table 2. Univariate Cox regression for DFS in the retrospective study.
| Variables | HR | 95% CI | P | |
|---|---|---|---|---|
| Pathological response | OPR VS Non-OPR | 11.05 | 1.54 to 79.45 | 0.02 |
| Age | >44 VS ≤44 years | 1.61 | 1.05 to 2.48 | 0.03 |
| Stage | IIA VS IB2 | 2.18 | 1.13 to 4.20 | 0.02 |
| IIB2 VS IB2 | 2.44 | 1.33 to 4.48 | 0.004 | |
| Tumor size | >4 cm VS ≤4 cm | 1.37 | 0.86 to 2.19 | 0.19 |
| Grade | G2 VS G1 | 2.16 | 0.67 to 7.01 | 0.20 |
| G3 VS G1 | 3.38 | 1.06 to 10.81 | 0.04 | |
| Undetermined VS G1 | 2.05 | 0.60 to 6.97 | 0.25 | |
| Cell type | Squamous VS non-squamous | 2.24 | 1.32 to 3.82 | 0.003 |
| LVSI | Positive VS negative | 1.40 | 0.75 to 2.61 | 0.29 |
| Parametrial infiltration | Positive VS negative | 2.61 | 1.53 to 4.44 | <0.001 |
| Vaginal surgical margin | Positive VS negative | 1.91 | 0.83 to 4.41 | 0.13 |
| Lymph node metastasis | Positive VS negative | 3.68 | 2.21 to 6.12 | <0.001 |
LVSI, Lymph vascular space invasion. DFS, disease free survival.